RHHBY Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 22:59):

Stats
Šios dienos apimtis	4.82M
Vidutinė apimtis	2.81M
Rinkos kapitalizacija	194.12B
EPS	$0.460 ( 2007-02-07 )
Kita pelno data	( $0 ) 2024-06-18
Last Dividend	$1.287 ( 2023-03-16 )
Next Dividend	$0 ( N/A )
P/E	15.30
ATR14	$0.00900 (0.03%)

Tūris Koreliacija

Ilgas: 0.14 (neutral)

Trumpas: -0.59 (weak negative)

Signal:(46.791) Neutral

Roche Holding AG Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Roche Holding AG Koreliacija - Valiuta/Žaliavos

0.22
( neutral )

0.49
( neutral )

0.00
( neutral )

0.38
( neutral )

0.23
( neutral )

Roche Holding AG Finansinės ataskaitos

Annual	2023
Pajamos:	$60.44B
Bruto pelnas:	$44.08B (72.94 %)
EPS:	$14.39

FY	2023
Pajamos:	$60.44B
Bruto pelnas:	$44.08B (72.94 %)
EPS:	$14.39

FY	2022
Pajamos:	$63.28B
Bruto pelnas:	$42.88B (67.77 %)
EPS:	$15.53

Financial Reports:

No articles found.

Roche Holding AG Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$1.287 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Roche Holding AG Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.61 - Stable (7.89%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.211	2005-02-28
Last Dividend	$1.287	2023-03-16
Next Dividend	$0	N/A
Payout Date	2023-03-27
Next Payout Date	N/A
# dividends	19	--
Total Paid Out	$16.76	--
Avg. Dividend % Per Year	0.00%	--
Score	2.88	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.61
Div. Directional Score	7.32	--

Next Divdend (Est)
(2024-12-31)

$0 Estimate 0.00 %

Dividend Stability

0.05 Very Bad

Dividend Score

2.88

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
SAFRY	Ex Dividend Junior	2023-05-30	Annually	0.00%
FETM	Ex Dividend Knight	2023-08-04	Quarterly	0.00%
YAMHF	Ex Dividend Junior	2023-12-28	Annually	0.00%
MCBI	Ex Dividend Junior	2023-08-04	Quarterly	0.00%
CKHGY	Ex Dividend Knight	2023-05-11	Annually	0.00%
SOUHY	Ex Dividend Junior	2023-09-14	Annually	0.00%
HARL	Ex Dividend Knight	2023-08-01	Quarterly	0.00%
AILIM	Ex Dividend Knight	2023-07-14	Quarterly	0.00%
NNGRY	Ex Dividend Junior	2023-09-07	Annually	0.00%
CPKF	Ex Dividend Knight	2023-08-31	Quarterly	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.194	1.500	6.12	9.18	[0 - 0.5]
returnOnAssetsTTM	0.191	1.200	3.65	4.37	[0 - 0.3]
returnOnEquityTTM	0.618	1.500	4.25	6.37	[0.1 - 1]
payoutRatioTTM	0.442	-1.000	5.58	-5.58	[0 - 1]
currentRatioTTM	1.347	0.800	8.26	6.61	[1 - 3]
quickRatioTTM	1.026	0.800	8.67	6.94	[0.8 - 2.5]
cashRatioTTM	0.217	1.500	9.91	10.00	[0.2 - 2]
debtRatioTTM	0.340	-1.500	4.33	-6.49	[0 - 0.6]
interestCoverageTTM	30.48	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	29.53	2.00	0.158	0.315	[0 - 30]
freeCashFlowPerShareTTM	21.35	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	1.050	-1.500	5.80	-8.70	[0 - 2.5]
grossProfitMarginTTM	0.734	1.000	1.092	1.092	[0.2 - 0.8]
operatingProfitMarginTTM	0.284	1.000	6.32	6.32	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.765	1.000	6.86	6.86	[0.2 - 2]
assetTurnoverTTM	0.983	0.800	6.78	5.42	[0.5 - 2]
Total Score				10.03

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	1.247	1.000	9.98	0	[1 - 100]
returnOnEquityTTM	0.618	2.50	6.30	6.37	[0.1 - 1.5]
freeCashFlowPerShareTTM	21.35	2.00	2.88	10.00	[0 - 30]
dividendYielPercentageTTM	5.81	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	29.53	2.00	0.158	0.315	[0 - 30]
payoutRatioTTM	0.442	1.500	5.58	-5.58	[0 - 1]
pegRatioTTM	0.0737	1.500	-2.84	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.265	1.000	5.88	0	[0.1 - 0.5]
Total Score				4.61

Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.